keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
D-Ala-Lys-AMCA TFA is a proton-coupled oligopeptide transporter 1 (PEPT1) substrate characterized by its emission of blue fluorescence. It has been demonstrated through fluorescence analysis that this compound can be transported into liver cancer cells and Caco-2 cells. Its utility extends to the characterization of PEPT1-specific substrates or inhibitors [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | D-Ala-Lys-AMCA TFA is a proton-coupled oligopeptide transporter 1 (PEPT1) substrate characterized by its emission of blue fluorescence. It has been demonstrated through fluorescence analysis that this compound can be transported into liver cancer cells and Caco-2 cells. Its utility extends to the characterization of PEPT1-specific substrates or inhibitors [1] [2]. |
In vitro | D-Ala-Lys-AMCA at concentrations of 25, 50, and 150 μM for a duration of three hours facilitates the transport of TFA to hepatocarcinoma and Caco-2 cells [1]. |
Molecular Weight | N/A |
keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
D-Ala-Lys-AMCA TFA inhibitor inhibit